Jul 20 2010 ↓Who Said What
Avastin, a drug primarily created by Roche to combat colon cancer showed tremendous promise for treating breast cancer as well. Yet the Food and Drug Administration has withdrawn its approval for the drug as a breast cancer medication 12 to 1 on grounds that Avastin, while promising, doesn’t really extend a patient’s life.
After more testing, it was said on Friday that the drug was not proven to extend women’s lives any more than other cancer treatments, such as chemotherapy.
Visit msnbc.com for breaking news, world news, and news about the economy
Avastin was originally given tentative approval as a drug to treat breast cancer when initial studies showed that the drug slowed the disease progress by a few months. The drug however did fail to proof that it also extended life.
According to Forbes:
“What really matters for a cancer drug is whether it helps the patient live longer. But those studies are very hard to do and take years. That’s why drug companies want to get drugs approved based on what are known as surrogate endpoints: Does the drug slow progression of the disease on a scan? Does it shrink tumors? But pretty-looking scans aren’t guaranteed to translate into fewer deaths. Maybe the disease will come back faster once the drug is stopped.”
A final decision will be made by the FDA after September 17 2010, when the FDA expects to receive the advisory panel’s recommendation regarding Avastin.
We understand the FDA’s position that life is a treasured commodity that must be preserved as long as possible. Still, to deny breast cancer patients, and for that matter, any other seriously ill individual, access to medications that possibly slows down the progress of this dreaded disease would be an injustice to those patients as they undoubtedly welcome any treatment that helps them with this awful illness, even if only a little bit.
3 Responses to “FDA Rejects Breast Cancer Drug Avastin”
What's Your Opinion?
You must be logged in to post a comment.
Got A Story? Email it to our news desk at Tip Line @ Nodeju.com
Patient Catches On Fire During Surgery
New York – During a tracheotomy procedure at the Lincoln hospital in New York, the head surgeon accidentally put the patient’s head on fire. When 52 year old Enrique Ruiz was placed on the surgery >> Full story
Premature Births In U.S. Equal To AfricaNEW YORK – Each year, 15 million babies are born prematurely worldwide and the United States has fared badly in the first global comparison of premature births, released by the World Health >> Full story
The Real Life Case of Benjamin Button LONDON – Actor Brad Pitt may have only been playing the character of a man growing younger in the film ‘The Curious Case of Benjamin Button’ but in the United Kingdom, two brothers are actually >> Full story
Obese America Is Costing Taxpayers Dearly WASHINGTON – From over-sized wheelchairs and gurneys to buses with bigger seats and stronger brakes, obese America is putting a heavy financial toll on the country’s health system. According to >> Full story
Nutella To Compensate American Consumers NEW YORK – Americans who purchased the popular Nutella coco spread last year can expect the company to reimburse them to the tune of up to $US3 million. A California mother filed a lawsuit against >> Full story

Facebook Is Largest Technology Company
Botched Butt Implants Leaves Woman Without Limbs
Three Cups Of Coffee A Day For A Longer Life
New York Woman Goes Shopping In The Nude
US Economy Is Going Backwards Once Again
Bangladesh Strike Errupts In Chaos And Violence
The 'Butcher of Srebrenica' Trial Has Begun
Latin Author Carlos Fuentes Has Died
Iraninan Rapper Condemned To Death Penalty
Philippines Judge With Pauper Wages Is Stinking Rich
Robert F. Kennedy JR. Ex Commits Suicide
Texting While Walking Could Get You Fined
Bride Found Dead Still Wearing Wedding Gown

[...] » FDA Rejects Breast Cancer Drug Avastin [...]
[...] FDA Rejects Breast Cancer Drug Avastin – Nodeju.com Logo [...]
[...] NDJ World | News Hot Trends and Views [...]